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GephyrinStressful experiences seem to negatively influence pain perception through as yet unknown mechanisms.
As the noradrenergic locus coeruleus (LC) nucleus coordinates many components of the stress response, as
well as nociceptive transmission, we evaluated whether the sensory and affective dimension of chronic
neuropathic pain worsens in situations of stress due to adaptive changes of LC neurons. Accordingly, male
rats were socially isolated for 5 weeks, and in the last 2 weeks, neuropathic pain was induced by chronic
constriction injury. In this situation of stress, chronic pain selectively heightened the animal’s aversion to
painful experiences (affective pain), as measured in the place escape/avoidance test, although no changes
were observed in the sensory dimension of pain. In addition, electrophysiological recordings of LC neurons
showed a low tonic but exacerbated nociceptive-evoked activity when the injured paw was stimulated.
These changes were accompanied by an increase in tyrosine hydroxylase and gephyrin expression in the
LC. Furthermore, intra-LC administration of bicuculline, a c-aminobutyric acid-A receptor antagonist, atten-
uated the negative affective effects of pain. These data show that changes in the LC are greater than those
expected from the simple summation of each independent factor (pain and stress), revealing mechanisms
through which stressors may exacerbate pain perception without affecting the sensorial dimension.
 2013 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.1. Introduction
Chronic neuropathic pain is a common problem for which ade-
quate treatments remain elusive. This is because the relationship
between the nociceptive input that originates at the injured nerve
and the resulting subjective pain experience is far from linear.
Stress has consistently been shown to be a factor that contributes
to the maintenance and amplification of the severity of pain
[17,39]. However, most such reports are correlational and the
underlying biological mechanisms remain unclear.
The main source of noradrenaline in the central nervous system
is the pontine locus coeruleus nucleus (LC), a structure that is clo-
sely linked to pain, stress, and emotions. Indeed, ascending noci-
ceptive inputs from the LC reach the forebrain, while its
descending projections innervate the spinal cord [33]. In addition,it is a structure that is essential to the cognitive branch of the stress
response and it is thought to be dysregulated in mental disorders
such as depression, anxiety, and posttraumatic stress disorder
[24,40]. In this sense, we have recently shown that long-term neu-
ropathic pain leads to anxio-depressive-like behaviour that is tem-
porally accompanied by an impairment of the LC [2]. Moreover,
antidepressants that inhibit the reuptake of noradrenaline can nor-
malize the nociceptive-evoked responses of LC neurons in rats that
experience neuropathic pain [3]. Thus, we hypothesized that stress
may trigger functional and/or structural changes in the LC that am-
plify pain. Accordingly, in this study we have evaluated the effect
of stress (social isolation) on the pain response and on the electro-
physiological/neurochemical properties of LC in neuropathic rats.
2. Methods
2.1. Animals and experimental design
Male Sprague-Dawley rats (University of Cadiz [ES110120000210],
Spain) were used in these studies, in accordance with the
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and the Spanish Law (RD 1201/2005). All the experimental proto-
cols were approved by the Committee for Animal Experimentation
at the University of Cadiz (Spain). Animals (weighing 200-220 g at
the beginning of the experiment) were housed under standard
laboratory conditions (water and food ad libitum, a constant room
temperature of 22 ± 1C, and a 12-hour light/dark cycle).
Neuropathic pain was induced by chronic constriction injury (CCI
[5,6]) whereby the common left sciatic nerve was ligated. In sham,
an identical dissection was performed in the left paw, but the sci-
atic nerve was not ligated. Stressed rats were housed individually
in standard plastic cages (22  22  14.5 cm), while control
animals were housed in groups of 4 in similar cages (21.5 
46.5  14.5 cm). Control rats were housed according to their pain
condition, that is, animals of the same cage belonged to the same
group (sham or CCI). The stress regime lasted for 5 weeks and,
where appropriate, neuropathic pain was induced during the third
week of stress (Fig. 1A). Thus, 4 groups were evaluated: Sham-con-
trol, Sham-stress, CCI-control, and CCI-stress.Fig. 1. Effect of neuropathic pain and stress on pain processing and anxiety-like be
constriction injury (CCI). Mechanical (B) and cold allodynia (C) in response to a von Frey m
measured by the place escape/avoidance test (PEAT). (E) Time spent in the open zone and
of buried marbles in the marble-burying test. The data are expressed as the mean ± SEM. ⁄
sham-stress; #P < 0.05; ##P < 0.01, vs CCI-control (n = 7-8 per group).2.2. Nociceptive behavioural testing
Sensory pain was evaluated before, as well as 1 and 2 weeks
after nerve injury (weeks 3, 4, and 5 of stress regime). The presence
of mechanical allodynia was measured using an automatic appara-
tus to apply the von Frey test (Dynamic Plantar Aesthesiometer,
Ugo Basile, Italy). This device uses a single nonflexible filament
that applies increasing force (from 0 to 50 g) against the plantar
surface of the hind paw over a 20-second period. The nocifensive
paw withdrawal response automatically turns off the stimulus,
and the mechanical pressure that evoked the response is recorded
[8]. Two measurements were taken for each paw at 5-minute inter-
vals and the mean value was considered the nociceptive threshold.
Cold allodynia was evaluated applying a drop of acetone (100 lL)
with a pipette to the centre of the ventral surface of the hind
paw [16]. Acetone was applied alternately 5 times to each hind
paw, at 5-minute intervals, and the responses were recorded over
a 1-minute period according to the following scale: 0, no response;
1, quick withdrawal, flick, or stamp of the paw; 2, prolongedhaviour. (A) Experimental design showing the programme of stress and chronic
onofilament and acetone, respectively. (D) Emotional/cognitive component of pain
(F) the number of entries into the closed zone in the elevated zero maze. (G) Number
P < 0.05; ⁄⁄P < 0.01; ⁄⁄⁄P < 0.001 vs sham-control; +P < 0.05; ++P < 0.01; +++P < 0.001 vs
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the paw with persistent licking directed at the ventral side of the
paw. The cumulative score for each rat was obtained by summing
the scores and dividing them by the number of assays.
2.3. Emotional behavioural testing
One set of animals was tested 5 weeks after stress in the place
escape/avoidance test (PEAT) to explore the affective-cognitive
dimension of pain [2,23]. Animals were placed in the centre of a
60  30  30 cm Plexiglas chamber on an elevated metal grid.
One half of the chamber was white and the other half of the cham-
ber was black. The rats were allowed to move freely throughout
the chamber over the 30-minute test period, during which they
were mechanically stimulated at 15-second intervals with a von
Frey monofilament (60 g) on the plantar surface of the hind paw,
depending on which area they were in. Thus, if the animals were
in the black side of the chamber, the left (ipsilateral) paw was stim-
ulated, whereas the right (contralateral) paw was stimulated when
they were in the white side. Each 30-minute test session was re-
corded and subsequently analyzed with SMART (Spontaneous Mo-
tor Activity Recording and Tracking) software. We scored the
proportion of time spent in the white area, binned into 5-minute
time intervals.
To evaluate anxiety-like behaviour, the elevated zero maze test
was performed after 5 weeks of stress [2]. After the animals were
placed in a closed section, they were allowed to investigate the
maze for 5 minutes, during which the time spent in the open zone
was evaluated. Additionally, the number of close zone entries was
recorded as indicative of motor behaviour. In addition, a marble-
burying test was carried out [27] in which the rats were placed
individually in a cage (21.5  46.5  14.5 cm) that contained 5-
cm deep bedding and 20 marbles (1.5 cm in diameter), arranged
in 5 by 4 rows. The test was performed over 30 minutes under
white light, after which the rats were removed and the buried mar-
bles counted. Marbles were considered buried if they were at least
three-quarters covered with bedding. A decrease in the proportion
of time spent in the open arms or an increase in the numbers of
marbles buried was considered as an index of anxiety behaviour
in the elevated zero maze test and marble buried test, respectively.
2.4. Intra-LC drug administration
At 4 days after CCI surgery, a parallel group of rats were anaes-
thetized and placed in a stereotaxic frame in order to implant a
stainless steel guide cannula unilaterally into the right (contralat-
eral) LC (relative to lambda and dural surface: anteroposterior
3.7 mm, midline 1.1 mm, and dorsoventral 6.2 mm; [32]).
The contralateral LC was pharmacologically explored because most
nociceptive inputs from periphery afferents decussate in the dorsal
horn at spinal cord level and then; nociceptive information ascends
to the contralateral LC neurons [33]. The cannula was fixed to the
skull with polyacrylic cement, anchored with stainless steel
screws, and it remained closed due to the insertion of a stainless
steel wire. A dose of the c-aminobutyric acid (GABA)-A receptor
antagonist, 1(S), 9(R)-()-bicuculline methiodide (10 ng per
0.5 lL; Sigma-Aldrich Chemicals, St. Louis, MO, USA), was dis-
solved in artificial cerebrospinal fluid and administered to the LC
5 minutes before the PEAT was performed. In addition, mechanical
allodynia was evaluated using the von Frey test before and after
the PEAT. To administer the drugs, animals were held gently while
the wire was removed and a removable injector was inserted into
the guide cannula, extending 1 mm beyond the guide tip. The
injector was linked to a 10-lL Hamilton syringe and the drug solu-
tion was injected over 30 seconds. The injector remained in the
guide cannula for a further 1 minute after infusion to allow thecompound to spread. At the end of each experiment, 0.5 lL of Pon-
tamine Sky Blue was used to mark the cannula site. The location of
the injection site was verified as being within the LC for all of the
animals that were included in this study.
2.5. Electrophysiological LC recordings
Single-unit extracellular recordings of LC neurons contralateral
to the operated hind paw were obtained 5 weeks after the start of
the stress regime in a parallel set of animals [1,7]. The recording
electrode was lowered into the LC (anteroposterior: 3.7 mm,
mediolateral: 1.1 mm relative to lambda and 5.0-7.0 mm from
brain surface after dura removal) [32]. LC neurons were identified
on the basis of well-established criteria [12]: long-duration action
potential (>2 ms), spontaneous firing at a regular rhythm, a slow fir-
ing rate between 0.5 and 5 Hz, and characteristic spikes with a long-
lasting positive-negative waveform (Fig. 2B). Firing patterns were
analyzed offline using the computer software Spike2 (Cambridge
Electronic Design, Cambridge, UK). At the end of each experiment,
the location of the recording site was verified (Fig. 2A). Only mea-
surements from cells within the LC were included in this study.
When a single unit was isolated, the tonic and the phasic
activity of LC neurons were measured. The coefficient of variation
(%) was expressed as the ratio of the SD to the mean interval value
of an interspike time-interval histogram; the burst firing discharge
was defined according to Grace and Bunney (1984) [20]; and histo-
grams of mean interspike interval (ISI) were defined as the fre-
quency of spike intervals for consecutive spikes. Phasic activation
(burst of action potentials) was elicited by paw compression (ipsi-
lateral or contralateral to injured paw) for 1 second between the
ends of a pair of 15-cm surgical forceps (Ref. 501742-G; World Pre-
cision Instruments, Hertfordshire, UK) by applying pressure mid-
way along the forceps such that the opposite sides of the forceps,
at this midpoint, came into contact. This sensory-evoked discharge
was followed by a postactivation inhibition or suppression period
(Fig. 2C) [21,41].
In another set of rats, intravenous (i.v.) dose-response curves
were constructed for UK14,304 (a2-adrenoceptor agonist; 2.5-
80.0 lg/kg; Tocris Bioscience, Bristol, UK) and desipramine (nor-
adrenaline reuptake inhibitor; 0.05-1.6 mg/kg; Sigma-Aldrich
Chemicals) in doubling dose. When complete inhibition was
achieved, LC neuron activity was reversed by i.v. administration
of the a2-adrenoceptor antagonists, RX821002 and idazoxan,
respectively (Sigma Chemical, St. Louis, Missouri). The effective
dose for eliciting 50% (ED50) of Emax (100%) was analyzed for the
best nonlinear fit to the logistic 3-parameter equation [31]. Only
one dose-response curve was obtained per rat.
2.6. Immunohistochemistry
One set of animals was perfused at the end of the experiments
[1] and 1 in each 4 free-floating sequential sections (30 lm) were
incubated with a sheep antityrosine hydroxylase (TH, 1:1000; Ab-
cam, Cambridge, UK) or a mouse monoclonal antigephyrin (mAb7a,
1:400; Synaptic Systems, Goettingen, Germany). Subsequently, the
sections were incubated with, respectively, a donkey antisheep
Alexa Fluor 568 (1:1000; Invitrogen, Madrid, Spain), or with biotin-
ylated donkey antimouse antibody (1:200; Jackson Immunore-
search Lab, West Grove, PA, USA) followed by Streptavidin 488
(1:1000; Invitrogen), before they were washed and coverslipped
with fluorogel aqueous mounting medium. TH-immunoreactivity
(TH-IR) was visualised on an Olympus BX60 microscope (Olympus
America, Center Valley, PA, USA) equipped with a U-MNU filter sys-
tem, and the number of cell bodies labelled (TH-IR) were counted
manually in an average of 6 sections of LC per animal (n = 4-5 rats
per group), by an experimenter blind to the conditions. The
Fig. 2. Effect of neuropathic pain and stress on the electrophysiological activity of locus coeruleus (LC). (A) Photomicrograph of a coronal section (Neutral Red stain) from the
rat brainstem showing the LC recording site (black arrow). 4V: 4th ventricle. (B) Representative oscillography trace of a typical LC neuron spike. (C) LC neuron typical response
pattern to hind paw compression. Note an increase of firing activity after stimulus followed by a quiescence period (suppression period). The latency period was the onset of
the sensory-evoked response (burst). (D) Spontaneous firing rate (Hz) of LC neurons in response to neuropathic pain and stress. CCI, chronic constriction injury. Data express
the mean ± SEM. ⁄P < 0.05 and ⁄⁄⁄P < 0.001 vs sham-control; +P < 0.05 vs sham-stress; ##P < 0.01 vs CCI-control. (E) Percentage of incidence of burst firing in the spontaneous
basal activity (tonic activity) and in response to contralateral hind paw compression (evoked activity). Data express the proportion (%) of neurons exhibiting burst activity
respect to total recording neurons. ⁄P < 0.05 and ⁄⁄⁄P < 0.001 vs sham-control. (F-G) Representative mean interspike interval (ISI) histograms showed regularity patterns of
electrical discharge of LC neurons recorded from (F) sham-control, sham-stress, and CCI-control. X-axis values indicate the number of spikes per bin (10 ms). Y-axis values
indicate the ISI distributions. (G) CCI-stress group did not show a Gauss distribution (dotted line) as seen in the rest of experimental groups. (H-I) Dose-response curves
illustrating the inhibitory effect of (H) UK14,304 and (I) desipramine (DMI), respectively, on the firing rate of LC neurons. Symbol represents the mean ± SEM of the reduction
percentage from the basal firing rate. The horizontal axis represents the logarithmic cumulative drug doses. (J-K) Representative oscillography traces illustrating the sensory-
evoked response of LC neurons to hind paw compression (black arrow) for (J) sham-control, sham-stress, CCI-control, and (K) CCI-stress groups. Note the increase of evoked
response in CCI-stress group; 12-16 animals per group were used for the electrophysiological recordings (see details in Table 2).
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Table 1
Analysis of variance (ANOVA) summary.
2- , 3- or 4-way ANOVA von Frey test Acetone test PEAT Bicuculline (10 ng/0.5 lL)
von Frey test PEAT
CCI F(1.24) = 335.12⁄⁄⁄ F(1.24) = 204.57⁄⁄⁄ F(1.26) = 47.89⁄⁄⁄ F(1.54) = 507.82⁄⁄⁄ F(1.54) = 28.30⁄⁄⁄
Stress F(1.24) = 0.64 F(1.24) = 0.06 F(1.26) = 6.70⁄ F(1.54) = 2.71 F(1.54) = 4.93⁄
Treatment    F(1.54) = 0.00 F(1.54) = 17.57⁄⁄⁄
CCI  stress F(1.24) = 0.30 F(1.24) = 5.19⁄ F(1.26) = 7.69⁄ F(1.54) = 0.02 F(1.54) = 3.33
CCI  treatment    F(1.54) = 0.02 F(1.54) = 6.35⁄
Stress  treatment    F(1.54) = 2.45 F(1.54) = 0.05
CCI  stress  treatment    F(1.54) = 3.00 F(1.54) = 1.62
Time F(2.48) = 57.02⁄⁄⁄ F(2.48) = 74.66⁄⁄⁄ F(5.130) = 1.40 F(1.54) = 0.79 F(5.270) = 3.28⁄⁄
Time  CCI F(2.48) = 66.83⁄⁄⁄ F(2.48) = 56.64⁄⁄⁄ F(5.130) = 8.97⁄⁄⁄ F(1.54) = 3.24 F(5.270) = 3.51⁄⁄
Time  stress F(2.48) = 1.25 F(2.48) = 0.16 F(5.130) = 0.37 F(1.54) = 0.11 F(5.270) = 0.97
Time  treatment    F(1.54) = 1.36 F(5.270) = 0.18
Time  CCI  stress F(2.48) = 0.18 F(2.48) = 0.20 F(5.130) = 0.18 F(1.54) = 0.60 F(5.270) = 0.65
Time  CCI  treatment    F(1.54) = 0.06 F(5.270) = 3.11⁄⁄
Time  stress  treatment    F(1.54) = 1.86 F(5.270) = 1.37
Time  CCI  stress  treatment    F(1.54) = 1.26 F(5.270) = 0.94
Two-way ANOVA CCI Stress CCI  stress
Behavioural tests
Elevated zero maze F(1.24) = 1.36 F(1.24) = 0.43 F(1.24) = 0.71
Marble-burying test F(1.24) = 0.05 F(1.24) = 0.32 F(1.24) = 0.09
Electrophysiological recordings
Tonic activity
Firing rate F(1.194) = 6.15⁄ F(1.194) = 9.81⁄⁄ F(1.194) = 2.48
Variation coefficient F(1.194) = 0.65 F(1.194) = 4.00⁄ F(1.194) = 4.71⁄
Burst rate F(1.194) = 0.54 F(1.194) = 11.74⁄⁄⁄ F(1.194) = 0.04
Spikes per burst F(1.57) = 4.19⁄ F(1.57) = 0.04 F(1.57) = 0.04
% Spikes in burst F(1.57) = 1.48 F(1.57) = 1.93 F(1.57) = 0.48
Evoked activity after ipsilateral paw compression
Latency F(1.85) = 11.3⁄ F(1.85) = 0.46 F(1.85) = 0.11
Spikes/s per burst F(1.85) = 3.60 F(1.85) = 2.80 F(1.85) = 5.14⁄
Suppression period F(1.85) = 3.60 F(1.85) = 1.90 F(1.85) = 2.90
Evoked activity after contralateral paw compression
Latency F(1.21) = 2.6 F(1.21) = 0.1 F(1.21) = 0.0
Spikes/s per burst F(1.21) = 2.6 F(1.21) = 0.1 F(1.21) = 0.1
Suppression period F(1.21) = 1.2 F(1.21) = 0.0 F(1.21) = 0.0
Immunohistochemistry studies
TH F(1.13) = 6.62⁄ F(1.13) = 6.94⁄ F(1.13) = 16.05⁄⁄
Gephyrin F(1.12) = 16.46⁄⁄ F(1.12) = 2.76 F(1.12) = 1.02
CCI, chronic constriction injury; TH, tyrosine hydroxylase; PEAT, place escape/avoidance test.
Data represent the F-values of 2-, 3-, and 4-way analysis of variance (ANOVA) of behavioural, electrophysiological, and immunohistochemistry studies. Ipsilateral and
contralateral terms refer to the injured paw. Significant results are indicated in bold. ⁄P < 0.05, ⁄⁄P < 0.01, and⁄⁄⁄ P < 0.001
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purposes. The expression of gephyrin was detected by using a Leica
Spectra Confocal microscope (Leica Microsystems Inc, Buffalo
Grove, IL, USA). A Z-stack consisting of 5-6 optical sections was ac-
quired with a 63X oil immersion from 2 randomized LC per rat
(n = 2 rats per group). Each z plane was analyzed by using a Macro
generated from ImageJ software (National Institutes of Health,
Bethesda, MD, USA), which converted the image to 8 bits and nor-
malized the background in respect to the control. Quantification of
gephyrin expression was performed as described elsewhere [35].
Thus, after normalizing the background, the number of clusters
was quantified (minimal cluster size of 0.1 lm2) by using a thresh-
old (70 on a 0-255 greyscale) for signal intensity that maximized
the selection of puncta and minimized the background noise. The
results were expressed as the number of clusters/100 lm2.
2.7. Statistical analysis
Data represent the mean ± SEM, and all the results were ana-
lyzed using either 2-, 3-, or 4-way analysis of variance, with or
without repeated measures, as appropriate. The factors of variance
were: CCI (between-groups), stress (between-groups), treatment
(bicuculline treatment, between-groups), and time (within-
groups) (see Table 1 for detailed statistical analysis). All further
post hoc analyses were carried out using a Bonferroni post hoc test.The burst incidence was analyzed by Fisher’s exact test. The level of
significance considered was P < 0.05.
3. Results
3.1. Nociceptive and emotional behavioural response
Animals subjected to 3 weeks of stress exhibited similar pain
thresholds when compared with nonstressed animals (control vs
stress groups: Fig. 1B-C). However, neuropathic rats (CCI-control
and CCI-stress) exhibited pronounced mechanical allodynia of
the operated hind paw in the von Frey test at week 4 and 5 of
the stress regime (P < 0.001; Fig. 1B). Moreover, they scored sig-
nificantly higher than the sham-control or sham-stress in the ace-
tone test (P < 0.001; Fig. 1C), reflecting cold allodynia. Overall, the
sensorial nociceptive responses of the ipsilateral hind paw were
similar in both CCI groups (CCI-control and CCI-stress), and no de-
crease in the pain threshold was observed in sham-stress. We
evaluated the affective-cognitive dimension of pain using the
PEAT at week 5 (2 weeks after neuropathy induction) (Fig. 1D).
As expected, CCI-control animals demonstrated a greater ten-
dency to escape from the dark side than the sham-operated rats.
Interestingly, the CCI-stress rats spent even more time within the
white area than the CCI-control animals, with significance at 5,
20, 25, and 30 minutes (P < 0.01, P < 0.05, P < 0.05, P < 0.05,
Table 2
Electrophysiological properties of locus coeruleus neurons.
Sham-control {16} CCI-control {12} Sham-stress {16} CCI-stress {16}
Tonic activity
Firing rate (Hz) 1.8 ± 0.1 1.7 ± 0.1 1.6 ± 0.1 1.2 ± 0.1⁄⁄⁄+##
Variation coefficient (%) 37.3 ± 1.6 39.4 ± 1.4 37.5 ± 1.6 33.0 ± 1.5#
Burst firing activity
Incidence (%) 42.3 (22/52) 30.7 (16/52) 28.6 (12/42) 21.2 (11/52)⁄
Burst rate (burst/ms) 11.0 ± 2.0 10.0 ± 3.0 5.0 ± 1.0 3.0 ± 1.0⁄#
Spikes per burst 2.1 ± 0.1 2.0 ± 0.0 2.2 ± 0.1 2.0 ± 0.0
Spikes in burst (%) 2.1 ± 0.3 2.9 ± 0.4 1.8 ± 0.4 2.1 ± 0.4
Evoked activity after ipsilateral paw compression
Incidence (%) 56.3 (31/55) 50.0 (20/40) 61.9 (13/21) 96.1 (25/26)⁄⁄⁄
Latency (ms) 581.9 ± 64.9 400.8 ± 32.3 561.1 ± 76.5 315.8 ± 34.1⁄⁄+
Spikes/s per burst 3.4 ± 0.2 4.3 ± 0.3 3.2 ± 0.3 4.6 ± 0.4⁄+#
Suppression period (s) 1.4 ± 0.1 1.4 ± 0.1 1.4 ± 0.0 1.1 ± 0.0
Evoked activity after contralateral paw compression
Incidence (%) 50.0 (8/16) 54.5 (6/11) 54.5 (6/11) 45.5 (5/11)
Latency (ms) 478.3 ± 31.5 419.3 ± 33.8 472.7 ± 34.0 402.2 ± 63.9
Spikes/s per burst 3.6 ± 0.3 4.0 ± 0.5 3.5 ± 0.2 4.0 ± 0.3
Suppression period (s) 1.1 ± 0.1 1.3 ± 0.2 1.1 ± 0.2 1.3 ± 0.1
Effective dose 50
UK14,304 (lg/kg) 21.8 ± 2.9 [6] 16.6 ± 3.0 [4] 21.0 ± 3.3 [6] 21.2 ± 3.9 [5]
Reversion (%) 81.4 ± 5.3 [6] 87.7 ± 26.6 [3] 96.5 ± 12.6 [6] 128.2 ± 26.5 [4]
Desipramine (mg/kg) 0.3 ± 0.1 [7] 0.2 ± 0.0 [5] 0.3 ± 0.1 [7] 0.2 ± 0.0 [8]
Reversion (%) 33.7 ± 5.0 [4] 35.1 ± 8.2 [4] 40.6 ± 11.4 [7] 40.8 ± 4.7 [7]
CCI, chronic constriction injury.
Data represent the mean ± SEM of tonic and sensory-evoked activity of locus coeruleus (LC) neurons in response to neuropathic pain and stress in {n} rats per group. Ipsilateral
and contralateral terms refer to the injured paw. The values in parentheses represent the LC neurons ratio exhibiting burst activity. The values in brackets represent the number of
pharmacologically tested neurons. The drug effective dose 50 was estimated by Parker and Waud’s equation. Complete inhibition of LC activity by UK14,304 and desipramine was
reversed by intravenous administration of RX821002 and idazoxan, respectively. The factor significance was represented as ⁄P < 0.05, ⁄⁄P < 0.01, and ⁄⁄⁄P < 0.001 vs sham-control;
+P < 0.05 vs sham-stress, #P < 0.05 and ##P < 0.01 vs CCI-control. The burst incidence was analyzed by Fisher’s exact test: ⁄P < 0.05 vs sham-control.
Fig. 3. Effect of neuropathic pain and stress on tyrosine hydroxylase (TH) and gephyrin expression by locus coeruleus (LC) neurons. (A) Graph depicting the number of TH
immunoreactive (TH-IR) neurons in LC and (B-E) representative photomicrographs of TH expression (red colour) in sections from (B) sham-control, (C) sham-stress, (D) CCI-
control, and (E) CCI-stress animals (n = 4-5 per group). The TH was found in the perikarya of LC neurons (magnification box). (F) The histogram shows the number of clusters
in each 100 lm2. (G-J) Representative photomicrographs of gephyrin expression (green colour) in sections containing the LC of (G) sham-control, (H) sham-stress, (I) CCI-
control, and (J) CCI-stress animals (n = 2 per group). Scale bars: (B-E) 100 lm and high magnification box: 15 lm, (G-J) 20 lm. Abbreviations: 4V, fourth ventricle; CCI, chronic
constriction injury. The data are expressed as the mean ± SEM. ⁄P < 0.05 vs sham-control; ++P < 0.01 vs sham-stress; #P < 0.05 and ##P < 0.01 vs CCI-control.
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fied in any group, because there were no differences in the time
spent in the open zone in the elevated zero maze (Fig. 1E) and
the number of close zone entries was similar in all groups, pre-
cluding a motor component in the observed effects (Fig. 1F). Sim-
ilarly, no differences were found in the marble-burying test
(Fig. 1G).
3.2. Electrophysiological activity of LC neurons
We evaluated any possible noradrenergic dysfunction by
exploring the tonic (spontaneous) firing of contralateral LC neurons(Table 2). Neither nerve injury (CCI-control) nor social isolation
(sham-stress) modified LC firing activity. However, when pain
and stress were combined (CCI-stress), they induced a lower tonic
firing rate and burst activity than that displayed by sham-operated
and CCI-controls (P < 0.001, P < 0.05, and P < 0.01, respectively: Ta-
ble 2 and Fig 2D), suggesting a decrease in activity of LC neurons.
Furthermore, ISI histograms from sham-control, sham-stress, and
CCI-control groups showed a similar Gaussian distribution of about
0.5 ms (Fig. 2F), reflecting a normal discharge pattern. However,
the CCI-stress group presented an obvious rightward shift in this
distribution with a greater number of ISI at intervals of about
1.0-1.5 ms (Fig. 2G). This abnormal distribution of ISI was
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stress (Table 2).
Alpha2-adrenoceptors play an important role in controlling the
firing activity of LC neurons, and consequently, in noradrenaline
release from noradrenergic fibres. Indeed, i.v. administration of
UK14,304 or desipramine inhibited spontaneous activity in a
dose-dependent manner, producing a similar ED50 and dose-re-
sponse curve in all experimental groups (Fig. 2H-I). Complete inhi-
bition of LC neuron activity by UK14,304 and desipramine
(Emax = 100%) was reversed by i.v. administration of the a2-adreno-
ceptor antagonists, RX821002 (100%) and idazoxan (30%),
respectively. Therefore, no differences were found regarding a2-
adrenoceptors function among groups (Table 2).
When we evaluated the sensory-evoked (phasic) activity of the LC
during ipsilateral paw compression, evoked discharge was slightly
enhanced in CCI animals when measured through the number of
spikes per burst. However, in CCI animals also subjected to stress,
both spikes per burst and the incidence of the response augmented
significantly (Fig. 2E). This effect was accompanied by a shortening
of the latency (Table 2 and Fig. 2J-K). These differences were not
found when the contralateral hind paw was compressed (Table 2).
3.3. TH and gephyrin expression at the LC Level
In another group of animals, we explored TH expression in the
LC by immunofluorescence, revealing that there was a significant
upregulation in the expression of TH in the LC (bilaterally) of the
CCI-stress animals with respect to the sham-control, sham-stress,
and CCI-control (P < 0.05, P < 0.01, P < 0.01 respectively: Fig. 3A,
B-E). By contrast, the animals that experienced just pain or stress
did not show any changes in the number of TH-IR neurons when
compared to the sham-control group. When we evaluated the
expression of gephyrin, a multifunctional protein selectively lo-
cated at inhibitory synapses [15] (Fig. 3F, G-J), there was also a sig-
nificant increase expression in CCI-stress when compared to the
sham-control or sham-stress rats (P < 0.01 and P < 0.05, respec-
tively, Fig. 3F). The expression of gephyrin was restricted to the
dendritic domains of TH-IR (Fig. 3J), which are specifically GABAer-
gic inhibitory innervations [14].
3.4. Effect of intra-LC bicuculline administration
As gephyrin expression was augmented in CCI-stress animals
and since the inhibitory modulation of LC neurons is thought to
be mediated mainly through GABA-A receptors, we evaluated the
effect of intra-LC (contralateral) bicuculline administration
(Fig. 4D). Bicuculline significantly decreased the time spent by
CCI-stressed animals in the white area (Fig. 4C), while it did not
modify the time spent in the white area of any of the sham-oper-
ated animals (Fig. 4B). Additionally, this effect seemed to be spe-
cific because no motor or behavioural impairment was evident in
this test (Speed in the white area [cm/s]: Vehicle: Sham-control:
4.4 ± 0.8, Sham-stress: 7.3 ± 1.6, CCI-control: 5.9 ± 1.1, CCI-
stress: 4.3 ± 0.7; Bicuculline: Sham-control: 5.9 ± 1.1, Sham-
stress: 3.1 ± 1.3, CCI-control: 4.8 ± 1.0, CCI-stress: 4.1 ± 0.4).
Moreover, intra-LC administration of bicuculline did not modify
the mechanical nociceptive pain threshold in any group (Fig. 4A).4. Discussion
Stress is considered a psychobiological factor that may have an
important adverse influence on the course of chronic pain. The pres-
ent study demonstrates that socially isolated neuropathic rats suffer
worse affective pain and that this effect is modulated by LC neurons.
We have explored the effect of being socially isolated on the
different dimensions of neuropathic pain perception. In thesensory-discriminative component, our results show that CCI rats
developed the same level of allodynia irrespective of whether they
were stressed by isolation. To evaluate the affective-cognitive ele-
ments, we have used the PEAT. This test evaluates the aversive nat-
ure of a noxious stimulus based on the avoidance of a preferred
location where the stimulus is delivered. Thus, the animals have
to choose between a dark nonanxiogenic area in which the injured
paw is stimulated and the white mildly anxiogenic region in which
the noninjured paw is stimulated [23]. As expected, we found that
CCI-controls spend more time in the white area than the sham-
control or sham-stress groups. However, the CCI-stress group spent
even more time in the white area, with the maximum avoidance
score. It is interesting to note that this effect was already evident
within 5 minutes after starting the test, suggesting that the ani-
mals are highly focused on pain avoidance, and that stress in-
creases the aversion to noxious stimulation.
It appears that anxiety did not compromise the results obtained
in the PEAT, as all the animals tested showed similar levels of
anxiety when evaluated in the elevated zero maze and marble-
burying tests. We previously found that 2 weeks of neuropathic
pain and chronic mild stress selectively increased the aversion to
painful stimuli, without affecting classic depressive-like behav-
iours measured through the forced swimming and anhedonia test
[10]. Thus, these and previous data corroborate that it takes
approximately 4 weeks for rats to develop affective disorders (anx-
iety and depression) in association with neuropathic pain
[2,19,37,43]. Nevertheless, further studies will be necessary to ex-
plore the effect of stress on the pain dimensions and secondary
affective disorders over longer periods.
Regarding LC function, tonic LC discharge activity was not
modified by either CCI or stress, consistent with previous data
[1,11,22]. However, the basal firing rate and bursting activity high-
lighted a significant decrease in the spontaneous activity of LC neu-
rons in CCI-stress. As the decrease of tonic activity could be
mediated by indirect activation of inhibitory a2-adrenoceptors
[25], we checked for possible overactivation of these receptors.
However, the dose-response curves of the a2-adrenoceptor agonist
UK14,304 and the noradrenaline reuptake inhibitor desipramine
were similar in all groups, ruling out such a hypothesis. When
we evaluated the expression of TH, the rate-limiting enzyme of
noradrenaline synthesis, there was no change after 5 weeks in iso-
lation or 2 weeks of neuropathic pain, consistent with the electro-
physiological data. An increase in TH has previously been seen in
the LC after stressful stimuli [26]. However, in other studies no
such changes were detected (using chronic footshock or restraint
stress [36]). This might also be the case in our model of stress, pos-
sibly because this short period of isolation alone is insufficient to
trigger a stress response in adult animals or alternatively, because
adaptive changes had already developed. On the other hand, while
we did not find any change in TH expression 2 weeks after CCI, an
increase was evident in group-housed rats after 4 weeks [2]. This
suggests that isolation might advance the changes observed 4
weeks after neuropathy is induced. However, it is important to
note that although both conditions lead to an increase in TH
expression, the electrophysiological situation is quite different. A
decrease in tonic and burst firing was observed in CCI-stressed rats
after 2 weeks, while there was no change in tonic activity, but
bursting activity and a2-adrenoceptors sensitivity was enhanced
in CCI-group-housed rats after 4 weeks [2]. Whereas behaviourally
isolated rats did not show any change in anxiety, their pain expe-
rience appeared to be heightened. By contrast, after 4 weeks, CCI
grouped rats consistently showed anxio-depressive-like behav-
iours [2] that were in accordance with the LC changes in the brain
tissue of depressed patients seen postmortem [28,29,45]. Together,
these data indicate that specific LC dysregulation might be linked
to different behavioural outcomes. It will be interesting to
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depressive disorders similar to those already described for CCI-
grouped housed rats, and whether they are accompanied by com-
parable alterations in the LC. Such information will help to link
behavioural alterations to specific brain signatures.
Neuropathic pain was previously shown to be associated with
higher glutamic acid decarboxylase expression and GABA release
in the LC [44]. Accordingly, gephyrin expression was slightly en-
hanced by nerve injury, but this expression was significantly ro-
bust when nerve injury was associated with stress, and it was
accompanied by functional changes such as lower and irregular to-
nic discharge. In addition, when a noxious mechanical stimulus
was applied to the injured paw, there was a trend in the CCI-con-
trol animals to increase the burst firing rate of the contralateral LC,
consistent with our previous data using an electrical train stimulus
[3]. As with the other parameters studied, this effect was very pro-
nounced in the CCI-stress group. Interestingly, no differences
among groups were found when the noninjured paw was stimu-
lated, suggesting that the exaggerated evoked response is re-
stricted to the nociceptive input from the injury (ascending pain
pathway). Therefore, CCI-stress altered the pattern of LC discharge
to noxious stimuli such that the ratio of evoked/tonic activity in-
creased, especially when the injured paw is stimulated. We pro-
pose that this might effectively enhance the LC-forebrainFig. 4. Behavioural testing after bicuculline administration: (A) Mechanical allodynia in
avoidance test (PEAT). (B-C) Emotional/cognitive component of pain measured by the PEA
Histological representation of the unilateral injection sites within the LC where the tip of
Bregma [32]). The data are expressed as the mean ± SEM. #P < 0.05 vs CCI-control. sP < 0.0
(n = 7-11 per group).signalling temporally linked to noxious events, increasing the
attention to pain perception in CCI-stress. Indeed, studies in pa-
tients have shown that attention to pain enhances perceived pain
[34,42]. It has been shown in awake animals that the LC facilitates
different behavioural outcomes by shifting between tonic and pha-
sic modes of discharge [4,40]. Thus, CCI-stress may shift the
physiological response of the LC-noradrenergic system toward a
phasic state when the injured paw is stimulated. This displacement
would augment the activation of the LC by a noxious stimulus and
consequently produce hyperarousal to perceived pain and stronger
avoidance to re-experience pain in conditions of CCI-stress in the
PEAT. That is, CCI-stress group has a more negative interpretation
of painful experiences in spite of similar sensorial pain and anxiety
threshold. Interestingly, it has been suggested in animal models
that the enhanced ratio of evoked/tonic activity of LC neurons is
causing the exaggerated response to trauma-related stimuli of
posttraumatic stress disorder [18]. A similar pattern was been
found in the LC of adult rats subjected to resident-intruder social
stress model [9].
Although several neurotransmitters have been shown to modu-
late tonic and sensory-evoked LC activity (eg, excitatory amino
acids, GABA, corticotropin-release-factor), our data as well as pre-
vious data point to an enhanced GABAergic neurotransmission in
the LC in neuropathic pain [38,44]. Thus, we explored the effectresponse to a von Frey monofilament before and after performing the place escape/
T in sham (B) and CCI groups. (C) [n] shows the dose of bicuculline in ng/0.5 lL. (D)
the injection cannula is represented by a black dot (9.30 to 10.04 mm posterior to
5, ssP < 0.01, sssP < 0.001 vs CCI-control [10]; dP < 0.05, ddP < 0.001 vs CCI-stress [10]
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GABA signals mainly through these receptors [14,30]. Results
showed that the intra-LC administration of bicuculline, a GABA-A
receptor antagonist, diminished the time spent in the white area
in the PEAT. Altogether, this suggests that GABA blockade at LC le-
vel attenuated the negative affective effects of pain inputs, proba-
bly due to a decrease of evoked/tonic activity ratio in the LC.
Further studies in the ipsilateral LC are necessary to make a
definitive statement about the role of GABA neurotransmission in
the ascending and descending pain pathway mediated by LC.
Current conceptualization of chronic pain is toward the integra-
tion of the obvious sensorial aspects, with other more diffuse, such
as psychological and social, variables that may explain different
patients’ outcomes [13]. In the current study, we have used ani-
mals to model pain perception when social network is removed
and could be translated to those neuropathic pain patients that
have or perceive altered social support (lack of supportive relation-
ships [hostility from family and/or friends], marital problems, lack
of financial support, belonging to disadvantaged groups [home-
less]). Our results show that when neuropathic pain is associated
with social isolation stress, there is a modified LC reaction to
noxious stimuli that exacerbate the response. As a consequence,
this greater reactivity to pain stimulus compromises the ability
of an individual to adapt to new contingencies. This might be an
adaptive LC response that aims to enhance the negative pain expe-
rience as a defensive reaction. These data, jointly with previous
ones about anxio-depressive-like disorders developed at long-term
neuropathic pain, are placing the brain noradrenaline system as a
key area mediating mood alterations in chronic pain.
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